Appraising the current role of chemotherapy for the treatment of sarcoma

Seminars in Oncology

Volumn 38, Issue SUPPL. 3, 2011, Pages

  D'Adamo, David R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MESNA; METHOTREXATE; NAVELBINE; PACLITAXEL; PALIFOSFAMIDE; SORAFENIB; SULINDAC; TAMOXIFEN; TEMOZOLOMIDE; TOPOTECAN; TRABECTEDIN; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT THERAPY; ANGIOSARCOMA; ARTICLE; BONE MARROW SUPPRESSION; BRAIN DISEASE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARDIOMYOPATHY; CARDIOTOXICITY; CHONDROSARCOMA; DISEASE FREE SURVIVAL; DRUG MEGADOSE; EWING SARCOMA; FIBROMATOSIS; HEARING IMPAIRMENT; HEMATURIA; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC CYSTITIS; HUMAN; LEIOMYOSARCOMA; LIPOSARCOMA; LIVER FAILURE; LIVER TOXICITY; LUNG TOXICITY; META ANALYSIS (TOPIC); MULTIPLE CYCLE TREATMENT; MYXOSARCOMA; NEPHROTOXICITY; NEUTROPENIA; OSTEOSARCOMA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SARCOMA; SENSORY NEUROPATHY; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; HUMANS; MEDICAL ONCOLOGY; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; OSTEOSARCOMA; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 80355123258     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.09.004     Document Type: Article

References (88)

1. K.M. Skubitz, and D.R. D'Adamo Sarcoma Mayo Clin Proc 82 2007 1409 1432 (Pubitemid 350060138)
2. S.W. Weiss, and J.R. Goldblum Enzinger and Weiss's soft tissue tumors 2001 Mosby St. Louis, MO
3. M. Brennan, K.M. Alektiar, and R. Maki Sarcomas of soft tissue and bone: soft tissue sarcoma V.T. DeVita Jr S. Hellman, S.A. Rosenbert, Cancer: principles and practice of oncology 6th ed. 2001 Lippincott, Williams and Wilkins Philadelphia, PA 1841 1891
4. National Comprehensive Cancer Network The NCCN Clinical Practice Guidences in Oncology (NCCN Guidelines): Soft Tissue Sarcoma Version 1.2011 NCCN.org Accessed March 24, 2011
5. National Comprehensive Cancer Network The NCCN Clinical Practice Guidences in Oncology (NCCN Guidelines): Bone Cancer Version 2.2011 NCCN.org Accessed March 24, 2011
6. R. Wesolowski, and G.T. Budd Use of chemotherapy for patients with bone and soft-tissue sarcomas Cleve Clin J Med 77 Suppl 1 2010 S23 S26
7. T.F. Delaney, J.C. Yang, and E. Glatstein Adjuvant therapy for adult patients with soft tissue sarcomas Oncology (Williston Park) 5 1991 105 118
8. I. Matushansky, and R.N. Taub Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma Nat Rev Clin Oncol 8 2011 434 438
9. B. O'Sullivan, A.M. Davis, and R. Turcotte Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial Lancet 359 2002 2235 2241 (Pubitemid 34717977)
10. J.C. Yang, A.E. Chang, and A.R. Baker Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity J Clin Oncol 16 1998 197 203 (Pubitemid 28041599)
11. A. Patrikidou, J. Domont, A. Cioffi, and A. Le Cesne Treating soft tissue sarcomas with adjuvant chemotherapy Curr Treat Options Oncol 12 2011 21 31
12. Sarcoma Meta-Analysis Collaboration Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data Sarcoma Meta-analysis Collaboration Lancet 350 1997 1647 1654
13. S. Frustaci, F. Gherlinzoni, and A. De Paoli Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial J Clin Oncol 19 2001 1238 1247 (Pubitemid 32202526)
14. S. Frustaci, A. De Paoli, and E. Bidoli Ifosfamide in the adjuvant therapy of soft tissue sarcomas Oncology 65 Suppl 2 2003 80 84 (Pubitemid 37346738)
15. T. Brodowicz, E. Schwameis, and J. Widder Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial Sarcoma 4 2000 151 160 (Pubitemid 32055721)
16. R. Petrioli, A. Coratti, and P. Correale Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma Am J Clin Oncol 25 2002 468 473 (Pubitemid 35154951)
17. P.J. Woll, M. van Glabbeke, P. Hohenberger EORTC Soft Tissue Bone Sarcoma Group Adjuvant chemotherapy with doxorubicin and ifosfamide in resected soft tissue sarcoma: interim analysis of a randomized phase III trial J Clin Oncol 25 18S 2007 abstract 10008
18. J.M. O'Connor, M. Chacón, F.E. Petracci, and R.D. Chacon Adjuvant chemotherapy in soft tissue sarcoma (STS): a meta-analysis of published data J Clin Oncol 26 Suppl 2008 abstract 10526
19. N. Pervaiz, N. Colterjohn, F. Farrokhyar, R. Tozer, A. Figueredo, and M. Ghert A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma Cancer 113 2008 573 581
20. B. O'Sullivan, A. Davis, and R. Turcotte Five-year results of a randomized phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma J Clin Oncol 22 14S 2004 abstract 9007
21. P.A. Meyers, G. Heller, and J. Healey Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience J Clin Oncol 10 1992 5 15
22. R.J. Grimer, S.R. Cannon, and A.M. Taminiau Osteosarcoma over the age of forty Eur J Cancer 39 2003 157 163 (Pubitemid 36057064)
23. th ed. 2009 CMP Medica Manhaset, NY
24. G. Bacci, A. Briccoli, and M. Rocca Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide Ann Oncol 14 2003 1126 1134 (Pubitemid 36950179)
25. G. Bacci, S. Ferrari, and F. Bertoni Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report J Clin Oncol 18 2000 4016 4027 (Pubitemid 32038393)
26. K. Winkler, G. Beron, and G. Delling Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response J Clin Oncol 6 1988 329 337 (Pubitemid 18065939)
27. S. Ferrari, S. Smeland, M. Mercuri Italian and Scandanavian Sarcoma Group Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups J Clin Oncol 23 2005 8845 8852 (Pubitemid 46211531)
28. F. Eilber, A. Giuliano, J. Eckardt, K. Patterson, S. Moseley, and J. Goodnight Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial J Clin Oncol 5 1987 21 26 (Pubitemid 17007852)
29. M.P. Link Adjuvant therapy in the treatment of osteosarcoma Important Adv Oncol 1986 193 207
30. M.P. Link, A.M. Goorin, and M. Horowitz Adjuvant chemotherapy of high-grade osteosarcoma of the extremity Updated results of the Multi-Institutional Osteosarcoma Study Clin Orthop Relat Res 270 1991 8 14
31. V.H. Bramwell, M. Burgers, and R. Sneath A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup J Clin Oncol 10 1992 1579 1591 (Pubitemid 23057988)
32. I.J. Lewis, M.A. Nooij, J. Whelan MRC BO06 and EORTC 80931 Collaborators; European Osteosarcoma Intergroup Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup J Natl Cancer Inst 99 2007 112 128
33. R.L. Souhami, A.W. Craft, and J.W. Van der Eijken Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup Lancet 350 1997 911 917 (Pubitemid 27420527)
34. P.A. Meyers, C.L. Schwartz, and M. Krailo Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate J Clin Oncol 23 2005 2004 2011 (Pubitemid 46211380)
35. V.H. Bramwell, W.P. Steward, and M. Nooij Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: a European Osteosarcoma Intergroup study J Clin Oncol 17 1999 3260 3269 (Pubitemid 29470661)
36. H.E. Grier, M.D. Krailo, and N.J. Tarbell Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone N Engl J Med 348 2003 694 701 (Pubitemid 36237038)
37. M. Paulussen, A.W. Craft, and I. Lewis European Intergroup Cooperative Ewing's Sarcoma Study-92 Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatmentcyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients J Clin Oncol 26 2008 4385 4393
38. A.D. Mitchell, K. Ayoub, D.C. Mangham, R.J. Grimer, S.R. Carter, and R.M. Tillman Experience in the treatment of dedifferentiated chondrosarcoma J Bone Joint Surg Br 82 2000 55 61 (Pubitemid 30060127)
39. E.L. Staals, P. Bacchini, and F. Bertoni Dedifferentiated central chondrosarcoma Cancer 106 2006 2682 2691
40. I.D. Dickey, P.S. Rose, and B. Fuchs Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes J Bone Joint Surg Am 2004 86 -A:2412-8
41. R.J. Grimer, G. Gosheger, and A. Taminiau Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group Eur J Cancer 43 2007 2060 2065 (Pubitemid 47380361)
42. M. Cesari, F. Bertoni, P. Bacchini, M. Mercuri, E. Palmerini, and S. Ferrari Mesenchymal chondrosarcoma An analysis of patients treated at a single institution Tumori 93 2007 423 427 (Pubitemid 350203913)
43. T.M. Dantonello, C. Int-Veen, I. Leuschner CWS Study Group; COSS Study Group Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups Cancer 112 2008 2424 2431
44. M.A. Clark, C. Fisher, I. Judson, and J.M. Thomas Soft-tissue sarcomas in adults N Engl J Med 353 2005 701 711 (Pubitemid 41175678)
45. K. Antman, J. Crowley, and S.P. Balcerzak An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas J Clin Oncol 11 1993 1276 1285 (Pubitemid 23199130)
46. K.H. Antman, and A. Elias Dana-Farber Cancer Institute studies in advanced sarcoma Semin Oncol 17 Suppl 2 1990 7 15 (Pubitemid 20060000)
47. V.H. Bramwell, D. Anderson, M.L. Charette Sarcoma Disease Site Group Doxorubicin-based chemotherapy for palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma Cochrane Database Syst Rev 3 2003 CD003293
48. J.H. Edmonson, L.M. Ryan, and R.H. Blum Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas J Clin Oncol 11 1993 1269 1275 (Pubitemid 23199129)
49. A. Elias, L. Ryan, A. Sulkes, J. Collins, J. Aisner, and K.H. Antman Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy J Clin Oncol 7 1989 1208 1216 (Pubitemid 19220122)
50. P. Lorigan, J. Verweij, Z. Papai European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Study Group Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study J Clin Oncol 25 2007 3144 3150 (Pubitemid 47218064)
51. A. Santoro, T. Tursz, and H. Mouridsen Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group J Clin Oncol 13 1995 1537 1545
52. M. Zalupski, B. Metch, and S. Balcerzak Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study J Natl Cancer Inst 83 1991 926 932
53. R.G. Maki, J.K. Wathen, and S.R. Patel Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of Sarcoma Alliance for Research Through Collaboration Study 002 J Clin Oncol 25 2007 2755 2763 (Pubitemid 47123184)
54. K.M. Leu, L.J. Ostruszka, and D. Shewach Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma J Clin Oncol 22 2004 1706 1712 (Pubitemid 41079810)
55. M. Scurr Histology-driven chemotherapy in soft tissue sarcomas Curr Treat Options Oncol 12 2011 32 45
56. M. Van Glabbeke, A.T. van Oosterom, and J.W. Oosterhuis Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimensa European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study J Clin Oncol 17 1999 150 157 (Pubitemid 29022388)
57. S. Sleijfer, M. Ouali, and M. van Glabbeke Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) Eur J Cancer 46 2010 72 83
58. L. Svancárová, J.Y. Blay, and I.R. Judson Gemcitabine in advanced adult soft-tissue sarcomas A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 38 2002 556 559 (Pubitemid 34185396)
59. S. Okuno, L.M. Ryan, J.H. Edmonson, D.A. Priebat, and R.H. Blum Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology Group Cancer 97 2003 1969 1973 (Pubitemid 36397273)
60. M.L. Hensley, R. Maki, and E. Venkatraman Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial J Clin Oncol 20 2002 2824 2831 (Pubitemid 34651511)
61. M.L. Hensley, J.A. Blessing, K. Degeest, O. Abulafia, P.G. Rose, and H.D. Homesley Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study Gynecol Oncol 109 2008 323 328
62. M.L. Hensley, J.A. Blessing, R. Mannel, and P.G. Rose Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial Gynecol Oncol 109 2008 329 334 (Pubitemid 351754961)
63. R.L. Jones, C. Fisher, O. Al-Muderis, and I.R. Judson Differential sensitivity of liposarcoma subtypes to chemotherapy Eur J Cancer 41 2005 2853 2860 (Pubitemid 41713123)
64. S.R. Patel, M.A. Burgess, C. Plager, N.E. Papadopoulos, K.A. Linke, and R.S. Benjamin Myxoid liposarcoma Experience with chemotherapy Cancer 74 1994 1265 1269
65. M.G. Fury, C.R. Antonescu, K.J. Van Zee, M.F. Brennan, and R.G. Maki A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy Cancer J 11 2005 241 247 (Pubitemid 44698813)
66. M. Schlemmer, P. Reichardt, and J. Verweij Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 44 2008 2433 2436
67. L. Kager, A. Zoubek, U. Pötschger Cooperative German-Austrian-Swiss Osteosarcoma Study Group Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols J Clin Oncol 21 2003 2011 2018 (Pubitemid 46606391)
68. J.C. Gentet, M. Brunat-Mentigny, and M.C. Demaille Ifosfamide and etoposide in childhood osteosarcoma A phase II study of the French Society of Paediatric Oncology Eur J Cancer 33 1997 232 237
69. M. Berger, G. Grignani, and S. Ferrari Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients Cancer 115 2009 2980 2987
70. D.M. Loeb, E. Garrett-Mayer, and R.F. Hobbs Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma Cancer 115 2009 2514 2522
71. B. Massimo, G. Grignani, and A. Giostra Phase II study of 153-samarium-EDTMP followed by haematopoietic stem cell for patients with osteosarcoma with bone metastasis J Clin Oncol 29 Suppl 2011 abstract 10040
72. J.S. Miser, M.D. Krailo, and N.J. Tarbell Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposidea Children's Cancer Group and Pediatric Oncology Group study J Clin Oncol 22 2004 2873 2876 (Pubitemid 41079906)
73. J. Alexander, N. Dainiak, and H.J. Berger Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography N Engl J Med 300 1979 278 283 (Pubitemid 9115687)
74. D.W. Northfelt, F.J. Martin, and P. Working Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma J Clin Pharmacol 36 1996 55 63 (Pubitemid 26058811)
75. S. Toma, A. Tucci, G. Villani, G. Carteni, N. Spadini, and R. Palumbo Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG) Anticancer Res 20 2002 485 491
76. I. Judson, J.A. Radford, and M. Harris Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 37 2001 870 877 (Pubitemid 32323965)
77. C.A. Felix Secondary leukemias induced by topoisomerase-targeted drugs Biochim Biophys Acta 1400 1998 233 255 (Pubitemid 28475107)
78. T.J. Postma, J.B. Vermorken, A.J. Liefting, H.M. Pinedo, and J.J. Heimans Paclitaxel-induced neuropathy Ann Oncol 6 1995 489 494
79. C. Rodriguez-Galindo, C.A. Poquette, and N.M. Marina Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors J Pediatr Hematol Oncol 22 2000 321 329 (Pubitemid 32290172)
80. W.P. Brade, K. Herdrich, U. Kachel-Fischer, and C.E. Araujo Dosing and side-effects of ifosfamide plus mesna J Cancer Res Clin Oncol 117 Suppl 4 1991 S164 S186
81. M. D'Incalci, E. Erba, and G. Damia Unique features of the mode of action of ET-743 Oncologist 7 2002 210 216 (Pubitemid 34651224)
82. P.G. Casali, R. Sanfilippo, and M. D'Incalci Trabectedin therapy for sarcomas Curr Opin Oncol 22 2010 342 346
83. A. Le Cesne, J.Y. Blay, and I. Judson Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group trial J Clin Oncol 23 2005 576 584 (Pubitemid 46224235)
84. G.D. Demetri, S.P. Chawla, and M. von Mehren Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules J Clin Oncol 27 2009 4188 4196
85. F. Grosso, R.L. Jones, and G.D. Demetri Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study Lancet Oncol 8 2007 595 602 (Pubitemid 46995623)
86. F. Grosso, R. Sanfilippo, and E. Virdis Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series Ann Oncol 20 2009 1439 1444
87. S. Jung, and B. Kasper Palifosfamide, a bifunctional alkylator for the treatment of sarcomas IDrugs 13 2010 38 48
88. C.C. Lau Molecular classification of osteosarcoma Cancer Treat Res 152 2009 459 465